刘吉华，博士，91porn 教授，博士研究生导师。主要从事中药生物技术、药效物质基础及作用机制、新药创制等研究工作。先后主持“十二五”国家重大新药创制专项、国家自然科学基金，教育部科学技术研究重点项目等多项课题研究。发表研究论文100余篇。获专利授权10余项。

代表论文主要有：

1. Rui Zhang^#, Mingxiao Li^#, Hui Tan, Jianyao Liu, Lu Wang, Wenling Dai*, Zhimin Fan*, Jihua Liu*. A new gut pathogenic bacteria and its metabolites promote colorectal cancer development and act as non-invasive early diagnostic biomarkers. Gut Microbes. 2025;17(1):2555446.

2. Yujie Yang^#, Shen Zhang, Jin Yang, Changheng Yao, Xue Li, Wenling Dai*, Jihua Liu*. The aqueous extract of Armadillidium vulgare Latreille alleviates neuropathic pain via inhibiting neuron-astrocyte crosstalk mediated by the IL-12-IFN-γ-IFNGR-CXCL10 pathway.J Ethnopharmacol. 2025;340:119173.

3. Mingxiao Li^#, Rui Zhang, Mingjie Xin, Yi Xu, Shijia Liu, Boyang Yu, Boli Zhang*, Jihua Liu*. Discovery and Validation of Potential Serum Biomarkerswith Pro-Inflammatory and DNA Damage Activities in Ulcerative Colitis: A Comprehensive Untargeted Metabolomic Study. Metabolites. 2022;12(10):997.

4. Wenling Dai^#, Yini Bao^#, Jifa Fan, Bin Ma, Shanshan Li, Wanli Zhao, Boyang Yu*, Jihua Liu*. Blockade of spinal dopamine D1/D2 receptor suppresses activation of NMDA receptor through Gαq and Src kinase to attenuate chronic bone cancer pain [J]. Journal of Advanced Research, 2021, 28: 139-148.

5. Zhao W, Liu M, Shen C, et al. Biosynthesis of plant-specific alkaloids tetrahydroprotoberberines in engineered Escherichia coli[J]. Green Chemistry, 2021, 23(16): 5944-5955.

6. Shanshan Li, Bin Ma, Jin Wang, Hengying Peng, Meng Zheng , Wenling Dai*, Jihua Liu*. Novel Pentapeptide Derived from Chicken by-Product Ameliorates DSS-Induced Colitis by Enhancing Intestinal Barrier Function via AhR-Induced Src Inactivation [J]. J Agric Food Chem, 2020, 68: 14192–14203